150
Participants
Start Date
July 31, 2010
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
Rifampicin in higher doses
Rifampicin 900 mg (study arm 2), and rifampicin 1200 mg (study arm 3)
Kibong'oto National Tuberculosis Hospital, Sanya Juu
Collaborators (1)
European and Developing Countries Clinical Trials Partnership (EDCTP)
OTHER_GOV
Sanofi
INDUSTRY
Kilimanjaro Christian Medical Centre, Tanzania
OTHER
Kibong'oto National Tuberculosis Hospital, Sanya Juu, Tanzania
UNKNOWN
University Centre for Chronic Diseases Dekkerswald, Groesbeek, The Netherlands
UNKNOWN
National Institute for Public Health and the Environment (RIVM)
OTHER_GOV
Radboud University Medical Center
OTHER